Thursday, March 19, 2015 2:21:28 PM
.... ok, so lately we've brought in some puzzle pieces for Greg Lemke <> Xetrios <> Salks Institute and a PS Targeting Patent and all other associated patents of Lemkes's and Salks all sold to "Kolltan"
so the puzzle gets bigger but at least we have a tie from Hakan Mellstedt to Gerald McMahon CEO of Kolltan...and PAV lists of some have shown Standish Fleming as well
enough for today..
-------------------------------------
Gordon Rustin M.D., MSc, FRCP Return to Angstrom Pharmaceuticals, Inc.
Member of Clinical Trial Advisory Board
David J. Chaplin
OXiGENE, Inc.
Board Affiliations
OXiGENE, Inc.
Tamar D. Howson
S*BIO Pte Ltd.
Board Affiliations
OXiGENE, Inc.
Adrian Lewellyn Harris
Collgard Biopharmaceuticals Ltd.
Board Affiliations
OXiGENE, Inc.
Angstrom Pharmaceuticals, Inc.
Frederick W. Driscoll
Flexion Therapeutics, Inc.
Board Affiliations
OXiGENE, Inc.
Gerald McMahon
Kolltan Pharmaceuticals, Inc.
Board Affiliations
OXiGENE, Inc.
Robert S. Kerbel
MetronomX, Pte. Ltd.
Board Affiliations
OXiGENE, Inc.
William D. Schwieterman
Avidia, Inc.
Board Affiliations
OXiGENE, Inc.
Stanley Kaye
Biotica Technology Limited
Board Affiliations
OXiGENE, Inc.
Dietmar W. Siemann
OXiGENE, Inc.
Board Affiliations
OXiGENE, Inc.
Jan B. Vermorken
Vaccinogen, Inc.
Board Affiliations
OXiGENE, Inc.
Lee S. Rosen
OXiGENE, Inc.
Board Affiliations
OXiGENE, Inc.
Hakan Mellstedt
Korea Stem Cell Bank Co., Ltd
Board Affiliations
OXiGENE, Inc.
Jeffrey S. Heier
Ophthalmic Consultants of Boston, Inc.
Board Affiliations
OXiGENE, Inc.
Hilary Calvert
Astex Therapeutics Limited
Board Affiliations
OXiGENE, Inc.
Standish M. Fleming
Forward Ventures
Board Affiliations
Nereus Pharmaceuticals, Inc.
Jason S. Fisherman
Synthesis Capital
Board Affiliations
Nereus Pharmaceuticals, Inc.
Erich Platzer
HBM Partners Ltd.
Board Affiliations
Nereus Pharmaceuticals, Inc.
Frank V. AtLee
Agenus Inc.
Board Affiliations
Nereus Pharmaceuticals, Inc.
Jim Van Heusden
Karolinska Development AB (publ)
Board Affiliations
Nereus Pharmaceuticals, Inc.
Martin Rosenberg
VantagePoint Capital Partners
Board Affiliations
Nereus Pharmaceuticals, Inc.
Gary Shearman
Neuro-Hitech, Inc.
Board Affiliations
Nereus Pharmaceuticals, Inc.
Kenneth C. Anderson
OncoPep, Inc.
Board Affiliations
Nereus Pharmaceuticals, Inc.
Lee Ellis
Cerulean Pharma Inc.
Board Affiliations
Nereus Pharmaceuticals, Inc.
Kobi M. Sethna
Nereus Pharmaceuticals, Inc.
Board Affiliations
Nereus Pharmaceuticals, Inc.
John C. Byrd
Nereus Pharmaceuticals, Inc.
Board Affiliations
Nereus Pharmaceuticals, Inc.
Peter O'Dwyer
TetraLogic Pharmaceuticals Corporation
Board Affiliations
Nereus Pharmaceuticals, Inc.
Martin Nash
Genetronics Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.
David C. U'Prichard
Druid Consulting, LLC
Board Affiliations
Angstrom Pharmaceuticals, Inc.
Donald W. Grimm
Aegis Therapeutics, LLC
Board Affiliations
Angstrom Pharmaceuticals, Inc.
Virgil D. Thompson
Spinnaker Biosciences, Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.
James A. Taylor
Innate Immunotherapeutics Limited
Board Affiliations
Angstrom Pharmaceuticals, Inc.
Stephen B. Howell
Aptose Biosciences Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.
Malcolm J. P. Finlayson
Angstrom Pharmaceuticals, Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.
Kerry Dance
Hamilton BioVentures
Board Affiliations
Angstrom Pharmaceuticals, Inc.
William R. Freeman
Spinnaker Biosciences, Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.
Bruce Dezube
Collgard Biopharmaceuticals Ltd.
Board Affiliations
Angstrom Pharmaceuticals, Inc.
Michael H. Silverman
Can-Fite BioPharma Ltd.
Board Affiliations
Angstrom Pharmaceuticals, Inc.
Nils Brünner
WntResearch AB
Board Affiliations
Angstrom Pharmaceuticals, Inc.
Jennifer Lorenzen
Angstrom Pharmaceuticals, Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.
Frederick E. Reno
Innate Immunotherapeutics Limited
Board Affiliations
Angstrom Pharmaceuticals, Inc.
Chi Yap
Angstrom Pharmaceuticals, Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.
Arup Das
Angstrom Pharmaceuticals, Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.
http://webcache.googleusercontent.com/search?q=cache:ymEFCzMQlAwJ:www.bloomberg.com/research/stocks/people/relationship.asp%3FpersonId%3D26576928%26ticker%3DOXGN%26previousCapId%3D1635374%26previousTitle%3DAngstrom%2520Pharmaceuticals%252C%2520Inc.+&cd=2&hl=en&ct=clnk&gl=us
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM